- Home
- HESM vs APGE Comparison
HESM vs APGE Comparison
Compare HESM & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HESM | APGE |
|---|---|---|
| Founded | 2014 | 2022 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.5B |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | HESM | APGE |
|---|---|---|
| Price | $37.31 | $69.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | $41.43 | ★ $103.33 |
| AVG Volume (30 Days) | ★ 1.5M | 1.0M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | ★ 8.18% | N/A |
| EPS Growth | N/A | ★ 1.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,495,500,000.00 | N/A |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $2.23 | N/A |
| P/E Ratio | $13.07 | ★ N/A |
| Revenue Growth | ★ 10.89 | N/A |
| 52 Week Low | $31.63 | $26.20 |
| 52 Week High | $44.14 | $84.56 |
Technical Indicators
Market Signals| Indicator | HESM | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 65.67 | 49.25 |
| Support Level | $35.73 | $66.00 |
| Resistance Level | $37.07 | $70.57 |
| Average True Range (ATR) | 0.81 | 4.15 |
| MACD | 0.13 | 0.65 |
| Stochastic Oscillator | 81.79 | 85.09 |
Price Performance
Historical ComparisonAbout HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.